Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

The impact of adrenergic signaling in skin cancer progression: possible repurposing of β-blockers for treatment of skin cancer.

Yang EV, Eubank TD.

Cancer Biomark. 2013;13(3):155-60. doi: 10.3233/CBM-130325. Review.

PMID:
23912487
2.

Use of ß-blockers and mortality following ovarian cancer diagnosis: a population-based cohort study.

Johannesdottir SA, Schmidt M, Phillips G, Glaser R, Yang EV, Blumenfeld M, Lemeshow S.

BMC Cancer. 2013 Feb 22;13:85. doi: 10.1186/1471-2407-13-85.

3.

Basal cell carcinoma: stressful life events and the tumor environment.

Fagundes CP, Glaser R, Johnson SL, Andridge RR, Yang EV, Di Gregorio MP, Chen M, Lambert DR, Jewell SD, Bechtel MA, Hearne DW, Herron JB, Kiecolt-Glaser JK.

Arch Gen Psychiatry. 2012 Jun;69(6):618-26. doi: 10.1001/archgenpsychiatry.2011.1535.

4.

Tumor site immune markers associated with risk for subsequent basal cell carcinomas.

Glaser R, Andridge R, Yang EV, Shana'ah AY, Di Gregorio M, Chen M, Johnson SL, De Renne LA, Lambert DR, Jewell SD, Bechtel MA, Hearne DW, Herron JB, Kiecolt-Glaser JK.

PLoS One. 2011;6(9):e25160. doi: 10.1371/journal.pone.0025160. Epub 2011 Sep 29.

5.

β-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study.

Lemeshow S, Sørensen HT, Phillips G, Yang EV, Antonsen S, Riis AH, Lesinski GB, Jackson R, Glaser R.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2273-9. doi: 10.1158/1055-9965.EPI-11-0249. Epub 2011 Sep 20.

6.

Role for catecholamines in tumor progression: possible use for β-blockers in the treatment of cancer.

Yang EV.

Cancer Biol Ther. 2010 Jul 1;10(1):30-2. Epub 2010 Jul 6. No abstract available.

7.

Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression.

Yang EV, Webster Marketon JI, Chen M, Lo KW, Kim SJ, Glaser R.

Brain Behav Immun. 2010 Oct;24(7):1089-96. doi: 10.1016/j.bbi.2010.04.013. Epub 2010 May 11.

8.

Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression.

Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, Barsky SH, Glaser R.

Brain Behav Immun. 2009 Feb;23(2):267-75. doi: 10.1016/j.bbi.2008.10.005. Epub 2008 Oct 21.

9.

Catecholamines can mediate stress-related effects on tumor progression.

Yang EV, Benson DM, Glaser R.

Expert Rev Endocrinol Metab. 2008 Nov;3(6):699-703. doi: 10.1586/17446651.3.6.699.

PMID:
30764060
10.

Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma.

Dittmer DP, Hilscher CJ, Gulley ML, Yang EV, Chen M, Glaser R.

Int J Cancer. 2008 Nov 1;123(9):2105-12. doi: 10.1002/ijc.23685.

11.

VEGF is differentially regulated in multiple myeloma-derived cell lines by norepinephrine.

Yang EV, Donovan EL, Benson DM, Glaser R.

Brain Behav Immun. 2008 Mar;22(3):318-23. Epub 2007 Nov 5.

12.

Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.

Yang EV, Sood AK, Chen M, Li Y, Eubank TD, Marsh CB, Jewell S, Flavahan NA, Morrison C, Yeh PE, Lemeshow S, Glaser R.

Cancer Res. 2006 Nov 1;66(21):10357-64.

13.

EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease.

Glaser R, Litsky ML, Padgett DA, Baiocchi RA, Yang EV, Chen M, Yeh PE, Green-Church KB, Caligiuri MA, Williams MV.

Virology. 2006 Mar 1;346(1):205-18.

14.

Effects of exogenous FGF-1 treatment on regeneration of the lens and the neural retina in the newt, Notophthalmus viridescens.

Yang EV, Wang L, Tassava RA.

J Exp Zool A Comp Exp Biol. 2005 Oct 1;303(10):837-44.

PMID:
16161011
15.

Stress-associated changes in the steady-state expression of latent Epstein-Barr virus: implications for chronic fatigue syndrome and cancer.

Glaser R, Padgett DA, Litsky ML, Baiocchi RA, Yang EV, Chen M, Yeh PE, Klimas NG, Marshall GD, Whiteside T, Herberman R, Kiecolt-Glaser J, Williams MV.

Brain Behav Immun. 2005 Mar;19(2):91-103.

PMID:
15664781
16.

Stress-associated immunomodulation and its implications for responses to vaccination.

Yang EV, Glaser R.

Expert Rev Vaccines. 2002 Dec;1(4):453-9. Review.

PMID:
12901583
17.

Stress-induced immunomodulation: Implications for tumorigenesis.

Yang EV, Glaser R.

Brain Behav Immun. 2003 Feb;17 Suppl 1:S37-40. Review. No abstract available.

PMID:
12615184
18.

Stress-related modulation of matrix metalloproteinase expression.

Yang EV, Bane CM, MacCallum RC, Kiecolt-Glaser JK, Malarkey WB, Glaser R.

J Neuroimmunol. 2002 Dec;133(1-2):144-50.

PMID:
12446017
19.

Stress-induced immunomodulation and the implications for health.

Yang EV, Glaser R.

Int Immunopharmacol. 2002 Feb;2(2-3):315-24. Review.

PMID:
11811934
20.

Stress-induced immunomodulation: impact on immune defenses against infectious disease.

Yang EV, Glaser R.

Biomed Pharmacother. 2000 Jun;54(5):245-50. Review.

PMID:
10917461
21.

Expression of Mmp-9 and related matrix metalloproteinase genes during axolotl limb regeneration.

Yang EV, Gardiner DM, Carlson MR, Nugas CA, Bryant SV.

Dev Dyn. 1999 Sep;216(1):2-9.

23.
25.
26.
27.

Paragonimiasis: treatment with praziquantel in 40 human cases and in 1 cat.

Cao WJ, He LY, Zhong HL, Xu ZS, Bi YC, Yu GT, Zhang QC, Li KC, Yang EV, She G, et al.

Arzneimittelforschung. 1984;34(9B):1203-4.

PMID:
6542394

Supplemental Content

Support Center